Hypertrophy of heart cells stimulated by pathological stress from cardiovascular disease increases the risk of morbidity and mortality, and inhibition of such hypertrophy is attracting increasing attention as a therapeutic strategy. McKinsey and Kass provide a comprehensive summary of small-molecule inhibitors of cardiac hypertrophy and intracellular signalling pathways that offer further promising therapeutic targets.
- Timothy A. McKinsey
- David A. Kass
